Tuesday Talk: Biotech News 2/23/15 to 2/27/15

Valeant Pharmaceuticals (VRX) & Salix Pharmaceuticals (SLXP) Valeant Pharmaceuticals had agreed to buy Salix Pharmaceuticals for about $10.4 billion dollars in an all cash type deal. Valeant currently has many approved drugs in various areas such as: skin, eyes, and oral type drugs. This addition of Salix Pharmaceuticals will give Valeant access to a gastrointestinal … Read more